MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
2.880
+0.050 (1.77%)
Sep 9, 2024, 4:00 PM EDT - Market closed
MDxHealth Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MDxHealth stock have an average target of 7.50, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 160.42% from the current stock price of 2.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
The average analyst rating for MDxHealth stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +143.06% | Mar 7, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +177.78% | Mar 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +108.33% | Nov 9, 2023 |
| TD Cowen | TD Cowen | Buy Initiates $7 | Buy | Initiates | $7 | +143.06% | May 31, 2023 |
| BTIG | BTIG | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +143.06% | May 16, 2023 |
Financial Forecast
Revenue This Year
87.35M
from 70.19M
Increased by 24.45%
Revenue Next Year
100.65M
from 87.35M
Increased by 15.22%
EPS This Year
-1.29
from -1.66
EPS Next Year
-0.83
from -1.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 90.4M | 110.3M | 127.1M | |
| Avg | 87.4M | 100.7M | 113.1M | |
| Low | 83.3M | 93.1M | 102.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 28.7% | 26.2% | 26.2% | |
| Avg | 24.4% | 15.2% | 12.4% | |
| Low | 18.7% | 6.6% | 2.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.27 | -0.75 | -0.44 | |
| Avg | -1.29 | -0.83 | -0.54 | |
| Low | -1.34 | -0.94 | -0.67 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.